skip to main content

Lung Cancer

Lung cancer will remain major health issue, despite falling rates

Date Visible: 
Tuesday, October 9, 2018 - 10:00

Smoking-related lung cancer rates are expected to drop dramatically over the next 50 years, but lung cancer will continue to be a significant health problem in the United States, says a University of Michigan researcher.

Reducing NOVA1 gene helps prevent tumor growth in most common type of lung cancer

Date Visible: 
Wednesday, August 8, 2018 - 19:45
Researchers have identified a gene that when inhibited or reduced, in turn, reduced or prevented human non-small cell lung cancer tumors from growing. When mice were injected with non-small cell lung cancer cells that contained the gene NOVA1, three of four mice formed tumors. When the mice were injected with cancer cells without NOVA1, three of four mice remained tumor-free.

Lung Cancer Screening Decisions Personalized

Date Visible: 
Tuesday, July 24, 2018 - 09:15
New research shows how to personalize the lung cancer screening decision for every patient. The results could help doctors fine-tune their advice to patients so that it’s based not only on a patient’s individual lung cancer risk and the potential benefits and harms of screening, but also the patient’s attitude about looking for problems and dealing with the consequences

Personalizing Lung Cancer Screening

Date Visible: 
Wednesday, June 6, 2018 - 12:45
A new study shows how to personalize the lung cancer screening decision for every patient. The results could help doctors fine-tune their advice to patients so that it’s based not only on a patient’s individual lung cancer risk and the potential benefits and harms of screening, but also the patient’s attitude about looking for problems and dealing with the consequences.

Immunotherapy cancer drugs may impact vision

Date Visible: 
Wednesday, May 9, 2018 - 15:30
Although it is rare, knowledge of this risk is important both for the ophthalmologists who treat it and for the oncologists prescribing the anti-cancer treatment, say Michigan Medicine researchers. The cases of three recent patients, published in JAMA Ophthalmology, highlight the issue. Patients receiving immune checkpoint inhibitors developed uveal effusions and eye inflammation that affected their vision.

1 in 7 lung surgery patients at risk for opioid dependence

Date Visible: 
Tuesday, January 30, 2018 - 10:00

Researchers found that 1 in 7 patients undergoing lung cancer surgery became new persistent opioid users after surgery, establishing opioid dependence as a postoperative complication that is as common as others, including atrial fibrillation.

A blood test can predict early lung cancer prognosis

Date Visible: 
Friday, September 1, 2017 - 12:45
Cancer cells obtained from a blood test may be able to predict how early-stage lung cancer patients will fare, a team from the University of Michigan has shown. This information could be used to determine which patients are most likely to benefit from additional therapies to head off the spread of the cancer to other areas of the body.

Pages